In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Immuno-Designed Molecules files for, withdraws €98.8mm IPO

Executive Summary

Cancer immunotherapeutics developer Immuno-Designed Molecules SA (IDM) has filed for and then withdrawn an IPO that would have been worth about €98.8mm ($120.7mm). It had hoped to sell about 8.1mm shares on the Nouveau Marche for €10.50-12.20 each.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Large Molecule
      • Antibodies
Deal Status
  • Withdrawn
Deal Type
  • Financing
    • IPO

Related Companies